Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7249339

Lung function changes by ethanol inhalation.

E Zuskin·A Bouhuys·M Sarić
View original source ↗Export metadata ↓

Abstract

The acute effect of ethanol inhalation on ventilatory capacity was studied in a group of six healthy volunteers and the results were compared to those obtained after the inhalation of a saline solution. There was a significant decrease in flow rates on partial expiratory flow-volume (PEFV) curves up to 90 min after ethanol inhalation. FEV1 values did not change significantly, either after ethanol or saline aerosol. Pretreatment with atropine did not prevent the acute reductions in flow rates in comparison with the reductions without atropine. Pretreatment with disodium cromoglycate (DSCG) considerably diminished the acute reductions of flow rates caused by ethanol inhalation. These results suggest that ethanol in some persons may act, at least partly, through releasing mediators with bronchoconstrictive action.

Explore related subjects

Administration, IntranasalAdultAerosolsAtropineDose-Response Relationship, DrugEthanolFemaleForced Expiratory Flow RatesForced Expiratory VolumeHumansMaleMaximal Expiratory Flow RateMiddle AgedRespiratory Function TestsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Zuskin, A Bouhuys, M Sarić. 1981. Lung function changes by ethanol inhalation.. https://doi.org/10.1111/j.1365-2222.1981.tb01590.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.

To determine the role of humoral mucosal immune response in protection against shigellosis, we have obtained a monoclonal dimeric immunoglobulin A (IgA) antibody specific for Shigella flexneri serotype 5a lipopolysaccharide (mIgA) and used a murine pulmonary infection model that mimics the lesions occurring in natural intestinal infection. Adult BALB/c mice challenged with 10(7) S. flexneri organisms developed a rapid inflammatory response characterized by polymorphonuclear cell infiltration around and within the bronchi and strong systemic interleukin 6 response. Implantation of hybridoma cells in the back of mice, resulting in the development of a myeloma tumor producing mIgA in the serum and subsequently secretory mIgA in local secretions, or direct intranasal administration of these antibodies, protected the animals against subsequent intranasal challenge with S. flexneri serotype 5a. Absence of histopathological lesion and significant decrease in bacterial load of the lungs and of systemic interleukin 6 response were the three major criteria of protection. This protection was shown to be serotype-specific and dependent on local concentration of mIgA. These data demonstrate that mucosal antibodies directed against a single polysaccharidic surface epitope of Shigella can protect against the disease.

Administration, Intranasal↗
PubMed1995

Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1.

The effect of murine rIL-4 on the development of herpesvirus encephalitis (HSE) in mice infected intranasally with herpes simplex virus type 1 (HSV-1) was investigated. The mortality rates of mice infected with a 0.5 LD50 dose of HSV-1 were greatly increased after the administration of rIL-4 at doses ranging from 0.01 to 1.0 U/mouse 2 h before and 2, 4 and 6 days after the infection. In contrast, survival rates of mice exposed to a 5 LD50 dose of HSV-1 were clearly increased when these mice were treated with anti-IL-4 mAb. Cervical lymph node (CLN) cells and cerebrospinal fluid (CSF) cells from mice with HSE (HSE mice) produced IL-4 in their culture fluids when they were stimulated in vitro with HSV-1 Ag. Increased amounts of HSV-1 infection in mice resulted in the increased production of IL-4 in the culture fluids of local lymphocytes. However, significant amounts of IL-4 were not produced in serum specimens or in culture fluids of spleen cells from HSE mice. IL-4 production in culture fluids of CLN and CSF cells from HSE mice was clearly reduced after treatment of HSE mice with anti-IL-4 mAb. Furthermore, IL-4 production by CLN and CSF cells was greatly enhanced when the cells were prepared from HSE mice previously treated with rIL-4. The IL-4 was mainly produced from CD4+ T cells. These results demonstrate that small amounts of exogenous IL-4 increase the severity of HSE in HSV-1-infected mice through the increased production of IL-4 from local CD4+ T cells.

Administration, Intranasal↗